RU2006102664A - Новый способ получения имипенема - Google Patents
Новый способ получения имипенема Download PDFInfo
- Publication number
- RU2006102664A RU2006102664A RU2006102664/04A RU2006102664A RU2006102664A RU 2006102664 A RU2006102664 A RU 2006102664A RU 2006102664/04 A RU2006102664/04 A RU 2006102664/04A RU 2006102664 A RU2006102664 A RU 2006102664A RU 2006102664 A RU2006102664 A RU 2006102664A
- Authority
- RU
- Russia
- Prior art keywords
- compound
- formula
- nitrobenzyl
- ketone
- group
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
- C07D477/02—Preparation
- C07D477/06—Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
- C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
- C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
- C07D477/20—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Hydrogenated Pyridines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Claims (9)
2. Способ получения соединения формулы II
где R1 представляет п-нитробензильную или п-метоксибензильную группу; и R2 и R3 могут быть одинаковыми или разными, и каждый независимо представляет С1-6 алкильную или арильную группу, путем сочетания соединения формулы IV
где R1 представляет п-нитробензильную или п-метоксибензильную группу, или его производного с гидрохлоридом 2-аминоэтантиола в присутствии основания с последующей реакцией с кетоном.
3. Способ по п.2, в котором кетон выбран из группы, состоящей из ацетона, метилэтилкетона, дифенилкетона и их смесей.
5. Способ по п.4, в котором растворитель для реакции является смешанным растворителем из ацетонитрила и тетрагидрофурана.
6. Способ по п.4, в котором температура реакции находится в интервале от 0 до -10С.
7. Способ получения соединения формулы I
путем взаимодействия соединения формулы II
где R1 представляет п-нитробензильную или п-метоксибензильную группу; и R2 и R3 могут быть одинаковыми или разными, и каждый независимо представляет С1-6 алкильную или арильную группу, с изопропилформимидатом или бензилформимидатом в присутствии основания с получением соединения формулы V
где R1 представляет п-нитробензильную или п-метоксибензильную группу, гидрирования соединения формулы V в присутствии катализатора-металла, выделения гидрированного соединения и кристаллизации выделенного соединения в присутствии спирта или кетона.
8. Способ по п.7, в котором гидрирование проводят в присутствии палладиевого катализатора, содержащего большое количество воды, при давлении водорода 4-6 кг/см2.
9. Способ по п.7, в котором растворитель для реакции является смешанным растворителем из воды и тетрагидрофурана.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20030088857 | 2003-12-09 | ||
KR10-2003-0088857 | 2003-12-09 |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2006102664A true RU2006102664A (ru) | 2006-08-10 |
RU2314308C2 RU2314308C2 (ru) | 2008-01-10 |
Family
ID=36642326
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2006102664/04A RU2314308C2 (ru) | 2003-12-09 | 2004-12-09 | Новый способ получения имипенема |
Country Status (14)
Country | Link |
---|---|
US (1) | US7507814B2 (ru) |
EP (1) | EP1692135A4 (ru) |
JP (1) | JP4500814B2 (ru) |
KR (1) | KR100667373B1 (ru) |
CN (1) | CN100383142C (ru) |
AU (1) | AU2004296261B2 (ru) |
BR (1) | BRPI0413057B8 (ru) |
CA (1) | CA2531578C (ru) |
MX (1) | MXPA06001115A (ru) |
NO (1) | NO20062602L (ru) |
NZ (1) | NZ547641A (ru) |
RU (1) | RU2314308C2 (ru) |
WO (1) | WO2005056553A1 (ru) |
ZA (1) | ZA200604446B (ru) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1395587B1 (en) * | 2001-05-18 | 2009-07-29 | Ranbaxy Laboratories Limited | Process for the preparation of imipenem |
KR100667373B1 (ko) * | 2003-12-09 | 2007-01-10 | 주식회사 중외제약 | 이미페넴의 신규 제조방법 |
CN102690266B (zh) * | 2011-09-02 | 2014-06-18 | 深圳市海滨制药有限公司 | 一种制备厄他培南钠的方法 |
CN108623598A (zh) * | 2018-05-21 | 2018-10-09 | 重庆天地药业有限责任公司 | 一种亚胺培南中间体及亚胺培南的制备方法 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4235920A (en) * | 1975-11-21 | 1980-11-25 | Merck & Co., Inc. | N-Alkylated derivatives of thienamycin |
GB1570988A (en) * | 1975-11-21 | 1980-07-09 | Merck & Co Inc | Antibiotics of the thienamycin class |
US4172144A (en) * | 1976-10-18 | 1979-10-23 | Merck & Co., Inc. | Schiff's base derivatives of thienamycin |
US4150145A (en) * | 1977-09-15 | 1979-04-17 | Merck & Co., Inc. | N-alkylated derivatives of thienamycin sulfoxide and sulfone |
US4292436A (en) | 1980-06-25 | 1981-09-29 | Merck & Co., Inc. | Process for the preparation of N-protected N-formimidoyl 2-aminoethanethiol |
US4845261A (en) | 1987-05-11 | 1989-07-04 | Merck & Co., Inc. | Process for bis(substituted phenyl) phosphorohalidates |
US4894450A (en) * | 1987-05-11 | 1990-01-16 | Merck & Co., Inc. | Process for 2-(aminoalkylthio) carbapenems |
IN191798B (ru) * | 2000-11-03 | 2004-01-03 | Ranbaxy Lab Ltd | |
ITMI20010077A1 (it) * | 2001-01-17 | 2002-07-18 | Acs Dobfar Spa | Procedimento per la produzione dell'imipenem |
EP1395587B1 (en) * | 2001-05-18 | 2009-07-29 | Ranbaxy Laboratories Limited | Process for the preparation of imipenem |
KR100667373B1 (ko) * | 2003-12-09 | 2007-01-10 | 주식회사 중외제약 | 이미페넴의 신규 제조방법 |
-
2004
- 2004-12-09 KR KR1020040103762A patent/KR100667373B1/ko active IP Right Grant
- 2004-12-09 WO PCT/KR2004/003224 patent/WO2005056553A1/en active Application Filing
- 2004-12-09 EP EP04808355A patent/EP1692135A4/en not_active Withdrawn
- 2004-12-09 JP JP2006523142A patent/JP4500814B2/ja active Active
- 2004-12-09 BR BRPI0413057A patent/BRPI0413057B8/pt active IP Right Grant
- 2004-12-09 NZ NZ547641A patent/NZ547641A/en unknown
- 2004-12-09 MX MXPA06001115A patent/MXPA06001115A/es active IP Right Grant
- 2004-12-09 AU AU2004296261A patent/AU2004296261B2/en active Active
- 2004-12-09 US US10/563,250 patent/US7507814B2/en active Active
- 2004-12-09 CA CA002531578A patent/CA2531578C/en active Active
- 2004-12-09 CN CNB2004800217450A patent/CN100383142C/zh active Active
- 2004-12-09 RU RU2006102664/04A patent/RU2314308C2/ru active
-
2006
- 2006-05-31 ZA ZA200604446A patent/ZA200604446B/en unknown
- 2006-06-06 NO NO20062602A patent/NO20062602L/no unknown
Also Published As
Publication number | Publication date |
---|---|
EP1692135A1 (en) | 2006-08-23 |
BRPI0413057B1 (pt) | 2018-02-06 |
AU2004296261A1 (en) | 2005-06-23 |
KR20050056161A (ko) | 2005-06-14 |
ZA200604446B (en) | 2007-10-31 |
MXPA06001115A (es) | 2006-04-11 |
JP4500814B2 (ja) | 2010-07-14 |
US20060167243A1 (en) | 2006-07-27 |
US7507814B2 (en) | 2009-03-24 |
WO2005056553A1 (en) | 2005-06-23 |
BRPI0413057A (pt) | 2006-10-17 |
AU2004296261B2 (en) | 2007-08-23 |
RU2314308C2 (ru) | 2008-01-10 |
CA2531578C (en) | 2008-10-07 |
EP1692135A4 (en) | 2009-02-25 |
BRPI0413057B8 (pt) | 2021-05-25 |
KR100667373B1 (ko) | 2007-01-10 |
CN100383142C (zh) | 2008-04-23 |
CN1829716A (zh) | 2006-09-06 |
NZ547641A (en) | 2009-02-28 |
NO20062602L (no) | 2006-08-31 |
JP2007501838A (ja) | 2007-02-01 |
CA2531578A1 (en) | 2005-06-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2585760C2 (ru) | Способ получения хиральных триазолонов | |
CA2861150C (en) | Morphinan derivative | |
CA2882386C (en) | Substituted pyrido[1,2-a]pyrazines and their use in the treatment of neurodegenerative and/or neurological disorders | |
EP0558156A2 (en) | Intermediates for 3-aminopiperidine derivates | |
Bhat et al. | Henry–Nef reaction: a practical and versatile chiral pool route to 2-substituted pyrrolidine and piperidine alkaloids | |
Damavandi | New approach to the multicomponent one-pot synthesis of 2-aryl-1 H-phenanthro [9, 10-d] imidazoles | |
FI87774C (fi) | Foerfarande foer framstaellning av terapeutiskt aktiva aralkylimidazolderivat | |
AU2013212209A1 (en) | (1R,4R) 7-oxo-2-azabicyclo[2.2.2]oct-5-ene and derivatives thereof | |
HU200755B (en) | Process for producing optically active alcohol derivatives by using asymmetrically modified compounds of boron hydride type | |
RU2006102664A (ru) | Новый способ получения имипенема | |
Jones et al. | Synthesis of 5-substituted 4-O-methyl tetramates | |
US20170355724A1 (en) | Anthelminthic macrolide synthesis | |
Hunt et al. | Chiral oxime ethers in asymmetric synthesis. Part 5. 1 Asymmetric synthesis of 2-substituted 5-to 8-membered nitrogen heterocycles by oxime addition–ring-closing metathesis | |
Mollet et al. | Stereoselective synthesis of bicyclic tetrahydrofuran-fused β-lactams and their conversion into methyl cis-3-aminotetrahydrofuran-2-carboxylates | |
Maison et al. | Synthesis of novel pipecolic acid derivatives: a multicomponent approach from 3, 4, 5, 6-tetrahydropyridines | |
Zhang et al. | Synthesis of 2-vinyl-2 H-benzotriazoles via NIS-promoted regio/stereoselective addition of 1H-benzotriazole to alkynes | |
EP1731509B1 (en) | Process for producing nitrogenous 5-membered cyclic compound | |
EP3507274B1 (de) | Verfahren zur herstellung chiraler aminonitrile | |
Liebeschuetz et al. | Rationally designed guanidine and amidine fungicides | |
Kotlyar et al. | Prospective biologically active compounds based on 5-formylthiazole | |
Schlüter et al. | Consecutive multicomponent reactions: synthesis of 3-Acyl-4-alkynyl-substituted 1, 3-thiazolidines | |
US8183365B2 (en) | Synthetic method for ceratamine A and B and analogs thereof | |
Naumova et al. | Three-step assembly of 4-aminotetrahydropyran-2-ones from isoxazoline-2-oxides | |
Sagirova et al. | Palladium-catalyzed diastereoselective hydrogenation of N-substituted 3-methyleneisoindolin-1-ones | |
EP0128120A2 (de) | Trisubstituierte Oxazolidinone |